Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Balabanova

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
Terapevticheskii Arkhiv|July 3, 2004
[Changes in indices of inflammatory activity in patients with rheumatoid arthritis during early stages of basic therapy with leflunomide]R M Balabanova, V I Makolkin, N A Shostak, et al.
Tuberkulez I Bolezni Legkikh|December 17, 2009
[Use of automated bactec MGIT 960 system in the diagnosis of resistance to reserve drugs agents in Samara]Ia M Balabanova, I M Fedorin, N A Malomanova, et al.
Problemy Tuberkuleza I Boleznei Legkikh|April 14, 2006
[Preponderance of Mycobacterium tuberculosis strains of the family Beijing and risk factors of their transmission in the Samara Region]Ia M Balabanova, V V Nikolaevskiĭ, M Raddi, et al.
Klinicheskaia Meditsina|July 26, 2002
[Nimesil effectiveness in rheumatoid arthritis]R M Balabanova, B S Belov, N V Chichasova, et al.
Problemy Tuberkuleza I Boleznei Legkikh|July 2, 2005
[Analysis of risk factors of the occurrence of drug resistance in patients with tuberculosis from civil and penitentiary sectors in the Samara Region]Ia M Balabanova, M Raddi, K Gram, et al.
Terapevticheskii Arkhiv|July 10, 2003
[Use of monoclonal antibodies to tumor necrosis factor (remicade) in rheumatoid arthritis: preliminary results]G V Lukina, Ia A Sigidin, N V Chichasova, et al.
Current Issues in Molecular Biology|January 24, 2025
Antiedemic Effect of the Myosin Light Chain Kinase Inhibitor PIK7 in the Rat Model of Myocardial Ischemia Reperfusion InjuryDmitry L Sonin, Mikhail S Medved, Asker Y Khapchaev, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
Terapevticheskii Arkhiv|July 3, 2004
[Changes in indices of inflammatory activity in patients with rheumatoid arthritis during early stages of basic therapy with leflunomide]R M Balabanova, V I Makolkin, N A Shostak, et al.
Tuberkulez I Bolezni Legkikh|December 17, 2009
[Use of automated bactec MGIT 960 system in the diagnosis of resistance to reserve drugs agents in Samara]Ia M Balabanova, I M Fedorin, N A Malomanova, et al.
Problemy Tuberkuleza I Boleznei Legkikh|April 14, 2006
[Preponderance of Mycobacterium tuberculosis strains of the family Beijing and risk factors of their transmission in the Samara Region]Ia M Balabanova, V V Nikolaevskiĭ, M Raddi, et al.
Klinicheskaia Meditsina|July 26, 2002
[Nimesil effectiveness in rheumatoid arthritis]R M Balabanova, B S Belov, N V Chichasova, et al.
Problemy Tuberkuleza I Boleznei Legkikh|July 2, 2005
[Analysis of risk factors of the occurrence of drug resistance in patients with tuberculosis from civil and penitentiary sectors in the Samara Region]Ia M Balabanova, M Raddi, K Gram, et al.
Terapevticheskii Arkhiv|July 10, 2003
[Use of monoclonal antibodies to tumor necrosis factor (remicade) in rheumatoid arthritis: preliminary results]G V Lukina, Ia A Sigidin, N V Chichasova, et al.
Current Issues in Molecular Biology|January 24, 2025
Antiedemic Effect of the Myosin Light Chain Kinase Inhibitor PIK7 in the Rat Model of Myocardial Ischemia Reperfusion InjuryDmitry L Sonin, Mikhail S Medved, Asker Y Khapchaev, et al.
Pageof 7